Last update 07 Jun 2025

Vascular endothelial growth factor gene therapy(Valentis, Inc.)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
Vascular endothelial growth factor gene therapy, VEGF-165 gene therapy
Target
VEGF-A
Action
modulators, inducers
Mechanism
VEGF-A modulators(Vascular endothelial growth factor A modulators), Angiogenesis inducers, Gene transference(Gene transference)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Myocardial IschemiaPeripheral Vascular Diseases
Originator Organization
Valentis, Inc.Valentis, Inc.
Active Organization-
Inactive Organization
Valentis, Inc.Valentis, Inc.
University of Eastern FinlandUniversity of Eastern Finland
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Vascular endothelial growth factor gene therapy(Valentis, Inc.)
Login to view more data
100 Translational Medicine associated with Vascular endothelial growth factor gene therapy(Valentis, Inc.)
Login to view more data
100 Patents (Medical) associated with Vascular endothelial growth factor gene therapy(Valentis, Inc.)
Login to view more data
100 Deals associated with Vascular endothelial growth factor gene therapy(Valentis, Inc.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Myocardial IschemiaPhase 2-
Valentis, Inc.Valentis, Inc.
-
Myocardial IschemiaPhase 2-
University of Eastern FinlandUniversity of Eastern Finland
-
Peripheral Vascular DiseasesPhase 2-
Valentis, Inc.Valentis, Inc.
-
Peripheral Vascular DiseasesPhase 2-
University of Eastern FinlandUniversity of Eastern Finland
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free